Decoy Therapeutics Inc. (DCOY)Healthcare | Biotechnology | Cambridge, United States | NasdaqCM
5.81 USD
-0.06
(-1.022%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 5.90 +0.09 (1.549%) ⇧ (April 17, 2026, 4:27 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:39 p.m. EDT
DCOY is currently in a severe short-term downtrend with a -27.9% downside projection from the forecasting model, driven by negative momentum post-reverse split; long-term prospects remain speculative given negative earnings, high R&D burn, and no analyst coverage, while the 0% dividend yield offers no income offset. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.218802 |
| AutoETS | 0.233469 |
| MSTL | 0.260463 |
| AutoTheta | 0.489521 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 9.03 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.301 |
| Excess Kurtosis | -0.32 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 3,091,001 |
| Forward P/E | -0.30 |
| Beta | 0.37 |
| Previous Name | Salarius Pharmaceuticals, Inc. |
| Website | https://decoytx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9532206 |
| Address1 | One Broadway |
| Address2 | 14th Floor |
| All Time High | 22,338,000.0 |
| All Time Low | 5.4 |
| Ask | 5.95 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 42,510 |
| Average Daily Volume3 Month | 27,699 |
| Average Volume | 27,699 |
| Average Volume10Days | 42,510 |
| Beta | 0.365 |
| Bid | 0.5482 |
| Bid Size | 1 |
| Book Value | 11.07 |
| City | Cambridge |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.81 |
| Current Ratio | 2.126 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.48 |
| Day Low | 5.55 |
| Display Name | Decoy Therapeutics |
| Ebitda | -4,088,835 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 1.863 |
| Enterprise Value | -7,619,203 |
| Eps Current Year | -12.96001 |
| Eps Forward | -19.32001 |
| Eps Trailing Twelve Months | -129.1 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.55006 |
| Fifty Day Average Change | -1.7400599 |
| Fifty Day Average Change Percent | -0.23046967 |
| Fifty Two Week Change Percent | -95.32206 |
| Fifty Two Week High | 415.8 |
| Fifty Two Week High Change | -409.99 |
| Fifty Two Week High Change Percent | -0.98602694 |
| Fifty Two Week Low | 5.4 |
| Fifty Two Week Low Change | 0.40999985 |
| Fifty Two Week Low Change Percent | 0.075925894 |
| Fifty Two Week Range | 5.4 - 415.8 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,422,541,800,000 |
| Float Shares | 528,441 |
| Forward Eps | -19.32001 |
| Forward P E | -0.30072448 |
| Free Cashflow | 1,822,354 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 11 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00585 |
| Held Percent Institutions | 0.124239996 |
| Implied Shares Outstanding | 532,014 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,773,014,400 |
| Last Split Factor | 1:12 |
| Long Business Summary | Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Cambridge, Massachusetts. |
| Long Name | Decoy Therapeutics Inc. |
| Market | us_market |
| Market Cap | 3,091,001 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_330031056 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -12,518,480 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,085,414 |
| Number Of Analyst Opinions | 1 |
| Open | 5.88 |
| Operating Cashflow | -4,827,188 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Post Market Change | 0.09000015 |
| Post Market Change Percent | 1.549056 |
| Post Market Price | 5.9 |
| Post Market Time | 1,776,457,661 |
| Prev Name | Salarius Pharmaceuticals, Inc. |
| Previous Close | 5.87 |
| Price Eps Current Year | -0.44830212 |
| Price Hint | 2 |
| Price To Book | 0.5248419 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.072 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.059999943 |
| Regular Market Change Percent | -1.0221455 |
| Regular Market Day High | 6.48 |
| Regular Market Day Low | 5.55 |
| Regular Market Day Range | 5.55 - 6.48 |
| Regular Market Open | 5.88 |
| Regular Market Previous Close | 5.87 |
| Regular Market Price | 5.81 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 35,295 |
| Return On Assets | -0.36363998 |
| Return On Equity | -3.38307 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 531,968 |
| Shares Percent Shares Out | 0.0363 |
| Shares Short | 19,296 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 25,550 |
| Short Name | Decoy Therapeutics Inc. |
| Short Percent Of Float | 0.0363 |
| Short Ratio | 0.62 |
| Source Interval | 15 |
| State | MA |
| Symbol | DCOY |
| Target High Price | 30.00001 |
| Target Low Price | 30.00001 |
| Target Mean Price | 30.00001 |
| Target Median Price | 30.00001 |
| Total Cash | 10,709,937 |
| Total Cash Per Share | 20.133 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -129.1 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 39.982117 |
| Two Hundred Day Average Change | -34.172115 |
| Two Hundred Day Average Change Percent | -0.854685 |
| Type Disp | Equity |
| Volume | 35,295 |
| Website | https://decoytx.com |
| Zip | 2,142 |